Although the CRP seems to have a predictive and prognostic value in rectal cancer patients treated with nCRT, it is a nonspecific marker of inflammation and might be influenced by several conditions, such as bacterial or viral infection, inflammatory diseases, connective tissue disorders, and medical treatments, although none of these conditions were identified in our cohort. The gene discussed is CRP; the disease is rectal cancer.